Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Frontage Holdings Corp. ( (HK:1521) ) has provided an announcement.
Frontage Holdings Corporation has updated the terms of reference for its Nomination Committee, which was originally established in 2018. The committee will consist of at least three non-executive directors, with a majority being independent and at least one member of a different gender, reflecting the company’s commitment to diversity and governance.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation operates within the pharmaceutical and biotechnology industry, providing research and development services to support drug discovery and development processes.
Average Trading Volume: 270,962
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$2.3B
For a thorough assessment of 1521 stock, go to TipRanks’ Stock Analysis page.